Feasibility and baseline findings of an educational intervention in a randomized trial to optimize drug treatment among residents in assisted living facilities

Abstract Purpose To describe the baseline findings and feasibility of a cluster randomized controlled trial of staff training to optimize the use of drugs among older residents in assisted living facilities. Methods Participants ( n =227) were recruited from assisted living facilities in Helsinki, Finland. Their wards were randomized into two arms: 1) intervention wards in which staff received training (2×4hours) to identify prescribing of harmful drugs; 2) control wards in which staff received training after completion of the intervention. Cognition, health-related quality-of life (HRQoL) by 15D and psychological well-being (PWB) were assessed of all participants. Demographics, diagnoses and drug use were verified from medical records. Drugs were categorized using anatomical therapeutic chemical (ATC) codes. The prevalence of anticholinergic, multiple psychotropic and Beers Criteria drugs was computed. Results The mean age of participants was 83years, 71% were females and 93% had dementia. The intervention and comparison groups did not differ with respect to cognition or PWB. However, the proportion of females and HRQoL was lower, and the Charlson comorbidity index higher in the intervention than in the control group. In addition, the prevalence of pro re nata (PRN) drugs, and the proportion using any harmful drug was higher in the intervention than in the control group. Staff training was received favourably by staff participants in the intervention wards. However, not all nurses participated in the training sessions, and there was some resistance to change working habits. Conclusions We have successfully randomized wards of assisted living facilities and trained staff in the intervention arm.

[1]  K. Pitkälä,et al.  Anticholinergic Drug Use and Mortality Among Residents of Long‐Term Care Facilities: A Prospective Cohort Study , 2011, Journal of clinical pharmacology.

[2]  K. Johnell,et al.  Institutionalization as a Risk Factor for Inappropriate Drug Use in the Elderly: A Swedish Nationwide Register-Based Study , 2012, The Annals of pharmacotherapy.

[3]  Lon S Schneider,et al.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.

[4]  Hannu Kautiainen,et al.  Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. , 2009, Journal of advanced nursing.

[5]  R. Aparasu,et al.  Antipsychotic drug use among elderly nursing home residents in the United States. , 2008, The American journal of geriatric pharmacotherapy.

[6]  H. Sintonen The 15D instrument of health-related quality of life: properties and applications , 2001, Annals of medicine.

[7]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[8]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[9]  C. Campanelli American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[10]  C. Hughes,et al.  Interventions to optimize prescribing for older people in care homes. (Protocol). , 2011 .

[11]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[12]  Jimmy D Bell,et al.  Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. , 2012, Journal of the American Medical Directors Association.

[13]  T. Strandberg,et al.  Detailed Cognitive Function and Use of Drugs with Anticholinergic Properties in Older People , 2013, Drugs & Aging.

[14]  Sirpa Hartikainen,et al.  Medication as a risk factor for falls: critical systematic review. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[16]  Robert Howard,et al.  Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial , 2006, BMJ : British Medical Journal.

[17]  S R Salem-Schatz,et al.  A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. , 1992, The New England journal of medicine.

[18]  Timothy F Chen,et al.  Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  R. Aparasu,et al.  Healthcare Outcomes Associated with Beers' Criteria: A Systematic Review , 2007, The Annals of pharmacotherapy.

[20]  T. Strandberg,et al.  Use of proton pump inhibitors and mortality among institutionalized older people. , 2010, Archives of internal medicine.

[21]  B. Vellas,et al.  Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. , 2002, Clinics in geriatric medicine.

[22]  C. V. D. van der Vleuten,et al.  Problem‐based learning: future challenges for educational practice and research , 2005, Medical education.

[23]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[24]  T. Strandberg,et al.  Association of Anticholinergic Drugs with Hospitalization and Mortality among Older Cardiovascular Patients , 2011, Drugs & aging.

[25]  S. Muurinen,et al.  Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland , 2008, Drugs & aging.

[26]  P. Miller,et al.  Interventions to optimise prescribing for older people in care homes. , 2016, The Cochrane database of systematic reviews.

[27]  R. McGlinchey,et al.  The anticholinergic risk scale and anticholinergic adverse effects in older persons. , 2008, Archives of internal medicine.

[28]  B. Svarstad,et al.  The Impact of Regular Multidisciplinary Team Interventions on Psychotropic Prescribing in Swedish Nursing Homes , 1998, Journal of the American Geriatrics Society.

[29]  C. Cardwell,et al.  An Evaluation of an Adapted U.S. Model of Pharmaceutical Care to Improve Psychoactive Prescribing for Nursing Home Residents in Northern Ireland (Fleetwood Northern Ireland Study) , 2010, Journal of the American Geriatrics Society.

[30]  K. Pitkälä,et al.  Use of Psychotropic Drugs in Elderly Nursing Home Residents with and without Dementia in Helsinki, Finland , 2005, Drugs & aging.

[31]  M. King,et al.  Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. , 2001, British journal of clinical pharmacology.

[32]  P. Phillips,et al.  Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. , 2004, The American journal of geriatric pharmacotherapy.

[33]  H. Kautiainen,et al.  Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial , 2012, Trials.

[34]  W. Ray,et al.  Predictors of Antipsychotic Withdrawal or Dose Reduction in a Randomized Controlled Trial of Provider Education , 1997, Journal of the American Geriatrics Society.

[35]  Maria Crotty,et al.  An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. , 2004, Age and ageing.

[36]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.